Published on 11/7/2005 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.
New Issue: Goldman prices $19 million 2.125% notes mandatorily exchangeable for pharmaceutical basket
New York, Nov. 7 - The Goldman Sachs Group, Inc. priced $19 million of 2.125% notes due May 8, 2006 mandatorily exchangeable for four stocks and one American Depositary Share, according to a 424B3 filing with the Securities and Exchange Commission.
The underlying stocks are Abbott Laboratories, Forest Laboratories, Inc., Eli Lilly and Co., Schering-Plough Corp. and GlaxoSmithKline plc ADS.
| Issuer: | The Goldman Sachs Group, Inc.
|
| Issue: | Mandatorily exchangeable series B medium-term notes
|
| Underlying stocks: | Abbott Laboratories, Forest Laboratories, Inc., Eli Lilly and Co., Schering-Plough Corp., GlaxoSmithKline plc ADS (equally weighted)
|
| Amount: | $19 million
|
| Maturity: | May 8, 2006, unless extended up to six business days
|
| Coupon: | 2.125%
|
| Price: | Par of $100.00
|
| Payout at maturity: | 0.4661 Abbott Laboratories shares, capped at $55.7817 per share, 30% above initial price; 0.5199 Forest Laboratories shares, capped at $50.0123 per share, 30% above initial price; 0.3853 GlaxoSmithKline ADS, capped at $67.4856 per ADS, 30% above initial price; 0.4006 Eli Lilly shares, capped at $64.9064 per share, 30% above initial price; 1.0110 Schering-Plough shares, capped at $25.7166 per share, 30% above initial price
|
| Exchange price: | $82.886 for Cummins, $54.534 for Lennar
|
| Lead manager: | Goldman, Sachs & Co.
|
| Pricing date: | Nov. 1
|
| Settlement date: | Nov. 8
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
